References
- Sharma SV, Haber DA, Settleman J. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 2010;10:241-253. https://doi.org/10.1038/nrc2820
- Gazdar AF, Girard L, Lockwood WW, Lam WL, Minna JD. Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst 2010;102:1310-1321. https://doi.org/10.1093/jnci/djq279
- Boutros M, Bras LP, Huber W. Analysis of cell-based RNAi screens. Genome Biol 2006;7:R66. https://doi.org/10.1186/gb-2006-7-7-r66
- Birmingham A, Selfors LM, Forster T, Wrobel D, Kennedy CJ, Shanks E, et al. Statistical methods for analysis of highthroughput RNA interference screens. Nat Methods 2009;6: 569-575. https://doi.org/10.1038/nmeth.1351
- Pelz O, Gilsdorf M, Boutros M. web cellHTS2: a web-application for the analysis of high-throughput screening data. BMC Bioinformatics 2010;11:185. https://doi.org/10.1186/1471-2105-11-185
- Rieber N, Knapp B, Eils R, Kaderali L. RNAither, an automated pipeline for the statistical analysis of high-throughput RNAi screens. Bioinformatics 2009;25:678-679. https://doi.org/10.1093/bioinformatics/btp014
- Whitehurst AW, Bodemann BO, Cardenas J, Ferguson D, Girard L, Peyton M, et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007;446: 815-819. https://doi.org/10.1038/nature05697
Cited by
- XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer vol.538, pp.7623, 2016, https://doi.org/10.1038/nature19771
- Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine vol.56, pp.5, 2015, https://doi.org/10.3349/ymj.2015.56.5.1186